ENTRY       D11123                      Drug
NAME        Mirikizumab (USAN/INN);
            Mirikizumab (genetical recombination) (JAN);
            Mirikizumab-mrkz;
            Omvoh (TN)
FORMULA     C6380H9842N1686O2004S48
EXACT_MASS  143676.665
MOL_WEIGHT  143765.6253
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGSSVKV SCKASGYKFT RYVMHWVRQA PGQGLEWMGY INPYNDGTNY
            NEKFKGRVTI TADKSTSTAY MELSSLRSED TAVYYCARNW DTGLWGQGTT VTVSSASTKG
            PSVFPLAPCS RSTSESTAAL GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA VLQSSGLYSL
            SSVVTVPSSS LGTKTYTCNV DHKPSNTKVD KRVESKYGPP CPPCPAPEAA GGPSVFLFPP
            KPKDTLMISR TPEVTCVVVD VSQEDPEVQF NWYVDGVEVH NAKTKPREEQ FNSTYRVVSV
            LTVLHQDWLN GKEYKCKVSN KGLPSSIEKT ISKAKGQPRE PQVYTLPPSQ EEMTKNQVSL
            TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSRLTVDKS RWQEGNVFSC
            SVMHEALHNH YTQKSLSLSL G
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCKASDHIL KFLTWYQQKP GKAPKLLIYG ATSLETGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQM YWSTPFTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H129-L214, H142-H198, H221-H'221, H224-H'224, H256-H316, H362-H420, H'22-H'96, H'129-L'214, H'142-H'198, H'256-H'316, H'362-H'420, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
CLASS       Immunological agent
             DG02019  Interleukin inhibitor
REMARK      Therapeutic category: 2399
            Product: D11123<JP>
EFFICACY    Anti-inflammatory, Antipsoriatic, Anti-IL-23 antibody
  DISEASE   Ulcerative colitis [DS:H01466]
  TYPE      Monoclonal antibody
TARGET      IL23A [HSA:51561] [KO:K05426]
  PATHWAY   hsa04060(51561)  Cytokine-cytokine receptor interaction
            hsa04630(51561)  JAK-STAT signaling pathway
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              23  Digestive organ agents
               239  Miscellaneous
                2399  Others
                 D11123  Mirikizumab (USAN/INN); Mirikizumab (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Immunological agent
              DG02019  Interleukin inhibitor
               D11123  Mirikizumab
            Drug classes [BR:br08332]
             Immunological agent
              DG02019  Interleukin inhibitor
               D11123  Mirikizumab
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interleukins
                IL23A
                 D11123  Mirikizumab (USAN/INN) &lt;JP&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11123
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11123
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11123
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11123
DBLINKS     CAS: 1884201-71-1
            PubChem: 376219047
///
